An early peak of relapse after surgery for breast cancer

Breast Cancer Research

Volumn 6, Issue 6, 2004, Pages 255-257

  Howell, Anthony ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Angiogenesis; Peak of relapse; Therapy; Wounding

Indexed keywords

ANGIOGENIC FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FUMAGILLOL CHLOROACETYLCARBAMATE; GROWTH FACTOR; STEROID RECEPTOR; TRASTUZUMAB; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER GROWTH; CANCER INHIBITION; CANCER RECURRENCE; HUMAN; HYPOTHESIS; LUNG METASTASIS; LYMPH NODE METASTASIS; NONHUMAN; POSTOPERATIVE PERIOD; PREMENOPAUSE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; SURGICAL RISK; SURGICAL WOUND; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 7444232140     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr946     Document Type: Article

References (16)

1. Demicheli R, Bonadonna G, Hrushesky WJM, Retsky MW, Valagussa P: Menopausal status dependence of the timing of breast cancer recurrence following primary tumour surgical removal. Breast Cancer Res 2004, 6:R689-R696.
2. Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G: Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat 1996, 41:177-185.
3. Saphner T, Tormey DC, Gray R: Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 1996, 14: 2738-2746.
4. Retsky M, Demicheli R, Hrushesky W: Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res Treat 2001, 65:217-224.
5. Demicheli R, Valagussa P, Bonadonna G: Does surgery modify growth kinetics of breast cancer micrometastases? Br J Cancer 2001, 85:490-492.
6. Demicheli R, Terenziani M, Bonadonna G: Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up? Breast Cancer Res Treat 1998, 51:133-137.
7. Klauber-DeMore N, Kimberly J, Van Zee KJ, Linkov I, Borgen PI, Gerald WL: Biological behaviour of human breast cancer micrometastases. Clin Cancer Res 2001, 7:2434-2439.
8. Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, Morris VL, Groom AC, Chambers AF: Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 2002, 62: 2162-2168.
9. Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van den Heuvel E, Harris AL, Jackson DG, Colpaert CG, Van Marck EA, Dirix LY, Vermeulen PB: Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer 2004, 90:1429-1436
10. Faneyte IF, Peterse JL, van Tinteren H, Pronk C,deVries EGE, Rodenhuis S, van de Vijver: Predicting early failure after adjuvant chemotherapy in high risk breast cancer patients with extensive lymph node involvement. Clin Cancer Res 2004, 10: 4457-4463.
11. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235: 77-182.
12. Nielson TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Blake Gilks C, van de Rijn M, Perou CM: Immunohistochemical and clinical characterisation of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004, 10:5367-5374.
13. Holmgren L, O'Reilly MS, Folkham J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Medicine 1995, 1:149-153.
14. Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E: Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 1989, 49:1996-2001.
15. Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, Martel M, Giovanazzi R, Greco M, Balsari A, Menard S: Role of HER2 in wound-induced breast carcinoma proliferation. Mechanisms of disease 2003, 362:527-533.
16. Hombrey E, Han C, Roberts A, McGrouther DA, Harris AL: The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clin Cancer Res 2003, 9:4332-4339.